Global Trends in Typhoid and Paratyphoid Fever, Clinical Infectious Diseases, vol.50, issue.2, pp.241-6649541, 2010. ,
DOI : 10.1086/649541
The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.98, issue.7, pp.423-453, 2004. ,
DOI : 10.1016/j.trstmh.2003.10.015
in Viet Nam: Molecular Basis of Resistance and Clinical Response to Treatment, Clinical Infectious Diseases, vol.25, issue.6, pp.1404-1414, 1997. ,
DOI : 10.1086/516128
Evolutionary History of Salmonella Typhi, Science, vol.314, issue.5803, pp.1301-41134933, 2006. ,
DOI : 10.1126/science.1134933
Clonal Expansion and Microevolution of Quinolone-Resistant Salmonella enterica Serotype Typhi in Vietnam from 1996 to 2004, Journal of Clinical Microbiology, vol.45, issue.11, pp.3485-9200948, 1996. ,
DOI : 10.1128/JCM.00948-07
Is It Time To Change Fluoroquinolone Breakpoints for Salmonella spp.?, Antimicrobial Agents and Chemotherapy, vol.47, issue.2, pp.827-9827, 2003. ,
DOI : 10.1128/AAC.47.2.827-829.2003
Clinical Response and Outcome of Infection with Salmonella enterica Serotype Typhi with Decreased Susceptibility to Fluoroquinolones: a United States FoodNet Multicenter Retrospective Cohort Study, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1278-8401509, 2008. ,
DOI : 10.1128/AAC.01509-07
Serotype Typhi and for Non???Typhi Salmonellae, Clinical Infectious Diseases, vol.37, issue.1, pp.75-81375602, 2003. ,
DOI : 10.1086/375602
Application of an In Vitro Infection Model and Simulation for Reevaluation of Fluoroquinolone Breakpoints for Salmonella enterica Serotype Typhi, Antimicrobial Agents and Chemotherapy, vol.49, issue.5, pp.1775-811775, 2005. ,
DOI : 10.1128/AAC.49.5.1775-1781.2005
Cases of typhoid fever imported into England, Scotland and Wales (2000???2003), Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.101, issue.4, pp.398-404, 2000. ,
DOI : 10.1016/j.trstmh.2006.07.005